Imaging Procedure Can Identify Biomarker Associated With Alzheimer's Disease, Avid Radiopharmaceuticals, Inc. Study  
1/26/2011 7:34:14 AM

ScienceDaily (Jan. 18, 2011) — Preliminary research suggests that use of a type of molecular imaging procedure may have the ability to detect the presence of beta-amyloid in the brains of individuals during life, a biomarker that is identified during autopsy to confirm a diagnosis of Alzheimer disease, according to a study in the January 19 issue of JAMA.